GERMANTOWN, Md., May 9, 2013 /PRNewswire/ -- Intrexon Corporation, a leader in synthetic biology that is helping companies design and develop products incorporating its Better DNA™, today announced it has aligned its industry markets to focus on four key sectors: Health, Food, Energy and Environment.
Intrexon currently has nine collaborations in Health and Food to create products embodying engineered bio-based solutions. The goal of the new market alignment is to accelerate business development across all of Intrexon's key market sectors using the company's Exclusive Channel Collaboration (ECC) model.
Since Intrexon's founding in 1998 the company has developed its core technology, the UltraVector® platform, to accelerate development of genetically-enhanced products at industrial scale. Using a dynamic library of more than two million diverse, modular genetic components, UltraVector enables the discovery, design, assembly and testing of a wide spectrum of multigenic biological systems.As part of its new market strategy, Intrexon named the following executives with deep industry experience to lead each market sector:
Chairman and Chief Executive Officer Randal J. Kirk said the new market alignment will help Intrexon achieve its vision to be one of the leading life science companies in the world.
"Our new sector organization, led by an outstanding team of industry veterans, will bring additional focus and rapidity to solving our partners' toughest synthetic biology problems," Kirk said. "It's a very exciting step toward empowering the bioindustrial revolution with solutions that enhance the quality and diversity of life."
About Intrexon CorporationIntrexon Corporation is a privately held biotechnology company focused on collaborating with companies in Health, Food, Energy and the Environment to create bio-based products that improve the quality of life and the health of the planet. Through the company's proprietary UltraVector® platform, Intrexon provides its partners with industrial-scale design and development of multigenic biology. UltraVector delivers unprecedented control over the quality, reliability, and performance of living cells. We call it Better DNA™ and we invite you to discover more at www.dna.com.
TrademarksIntrexon, UltraVector, mAbLogix and Better DNA are trademarks of Intrexon and/or its affiliates. Other names may be trademarks of their respective owners.
Safe Harbor StatementSome of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.
For more information regarding Intrexon Corporation, contact:Corporate Contact:Investor Contact:Marie L. Rossi, Ph.D.The Ruth GroupManager, Technical Communications
Tel: +1 301-556-9944
Stephanie Carrington / Melanie Sollid-Penton
Tel: +1 646-536-7017/7009
|SOURCE Intrexon Corporation|
Copyright©2012 PR Newswire.
All rights reserved